Fractional-submerged membrane distillation crystallizer (F-SMDC) for treatment of high salinity solution

© 2018 Elsevier B.V. Membrane distillation with crystallization (MDC) is an attractive process for high saline seawater reverse osmosis (SWRO) brine treatment. MDC produces additional fresh water while simultaneously recovering valuable resources. This study developed a novel approach of fractional-submerged MDC (F-SMDC) process, in which MD and crystallizer are integrated in a feed tank with a submerged membrane. F-SMDC principle is based on the presence of temperature/concentration gradient (TG/CG) in the feed reactor. The operational conditions at the top portion of the feed reactor (higher temperature and lower feed concentration) was well suited for MD operation, while the bottom portion of the reactor (lower temperature and higher concentration) was favourable for crystal growth. F-SMDC performance with direct contact MD to treat brine and produce sodium sulfate (Na2SO4) crystals using TG/CG showed positive results. The TG/CG approach in F-SMDC enabled to achieve higher water recovery for brine treatment with a volume concentration factor (VCF) of over 3.5 compared to VCF of 2.9 with a conventional S-MDC set-up. Further, the high feed concentration and low temperature at the reactor bottom in F-SMDC enabled the formation of Na2SO4 crystals with narrow crystal size distribution

Effect of chemical and physical factors on the crystallization of calcium sulfate in seawater reverse osmosis brine

© 2017 Elsevier B.V. A major challenge of seawater reverse osmosis (SWRO) desalination process corresponds to the management of concentrated brine waste because discharging the brine back into the sea influences the marine ecosystem and incurs additional costs to plants. A membrane distillation crystallizer (MDC) can further produce clean water and simultaneously recover valuable resources from the concentrated brine; this is more environmentally and economically optimal. SWRO brine contains salts, which contribute to scaling development during the MDC operation. Hence, the main goals of this study was to observe the crystallization tendency of calcium sulfate (CaSO4) under high salinity and, to examine other inorganic and organic compounds and operational conditions that affect the CaSO4 crystallization. The crystallization tendency of CaSO4 in SWRO brine was examined with respect to different temperatures; changes in pH values; and in the presence of co-existing ions, chemical agents, and organic matters as well as physical factors. The results showed that the size and quantity of crystals formed increased at higher temperatures. Furthermore, an increase in the pH values increased the crystal size. At higher pH, the complexion of NaCl along with CaSO4 was created. Moreover, stirring enhanced CaSO4 crystal formation due to the kinetic mechanism

Valuable rubidium extraction from potassium reduced seawater brine

© 2017 Elsevier Ltd Extraction of rubidium (Rb) which is an economically valuable metal from seawater reverse osmosis (SWRO) brine is beneficial. However, potassium (K) in SWRO brine hinders Rb extraction. Natural clinoptilolite zeolite in powder form was able to selectively remove K from SWRO brine (Langmuir maximum sorption, Qmax (cal.) = 57.47 ± 0.09 mg/g). An integrated submerged membrane sorption reactor (SMSR) containing zeolite powder achieved 65% K removal from SWRO brine. Periodic replacement of zeolite in SMSR, coupled with membrane backwashing was effective in maintaining a high K removal efficiency and a stable transmembrane pressure. Less than 5% Rb losses occurred along with K sorption, establishing the high K selectivity by zeolite in SWRO brine. Utilization of K loaded zeolite as a slow release fertilizer would be beneficial for agriculture. In SWRO brine with reduced K contents, the Rb sorption efficiency of polymer encapsulated potassium copper hexacyanoferrate (KCuFC(PAN)) sorbent, increased significantly from 18% to 83%

Hydrogen production affected by Pt concentration on TiO <inf>2</inf> produced from the incineration of dye wastewater flocculated sludge using titanium tetrachloride

TiO 2 from the incineration of dye wastewater flocculated sludge using TiCl 4 coagulant was produced. Optimal catalyst amount and Pt-loading on TiO 2 were studied for the production of H 2 by photocatalytic reforming of methanol (6% vol.). On the other hand, BTSE (biologically treated sewage effluent) was flocculated using TiCl4 and produced sludge was incinerated to generate TiO 2 . TiO 2 was loaded with optimum Pt and added to the supernatant in a photocatalytic reactor to test the efficiency of using remaining organics as a “sacrificial reagent” for photocatalytic hydrogen production. Dissolved organic carbon (DOC) and molecular weight distribution (MWD) were measured for nanofiltration (NF) and TiCl 4 flocculation followed by photocatalysis. TiO 2 (from the incineration of BTSE flocculated sludge using TiCl4) was produced and loaded with 0.5% Pt. Results showed that the optimum concentration of TiO 2 (from dye wastewater) for H 2 production was 0.3 g/L, while the optimum amount of Pt was 0.5%. DOC and MWD removal was similar for the flocculation of BTSE followed by photocatalytic reaction and the NF process. Remaining organic compounds after flocculation could not be used as sacrificial reagent to induce H 2 production. Further investigations on studying the UV intensity and/or identifying organic/inorganic scavengers to inhibit H 2 production are underway. © 2010, Taylor & Francis Group, LLC

Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis

Tumour growth depends on angiogenesis, which is closely associated with vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs). Extracellular MMP inducer (EMMPRIN) was reported to involve in the progression of malignancies by regulating expression of VEGF and MMPs in stromal cells. To clarify the role of EMMPRIN in progression and angiogenesis of gastric carcinoma, expression of EMMPRIN, ki-67, MMP-2, MMP-9 and VEGF was examined on tissue microarray containing gastric carcinomas (n=234) and non-cancerous mucosa adjacent to carcinoma (n=85) by immunohistochemistry. Additionally, microvessel density (MVD) was assessed after labelling with anti-CD34 antibody. Extracellular MMP inducer expression was compared with clinicopathological parameters of tumours, including levels of ki-67, MMP-2, MMP-9 and vascular endothelial growth factor (VEGF), MVD as well as survival time of carcinoma patients. Gastric carcinoma cell lines (HGC-27, MKN28 and MKN45) were studied for EMMPRIN expression by immunohistochemistry and Western blot. Extracellular MMP inducer expression was gradually increased from normal mucosa to carcinomas through hyperplastic or metaplastic mucosa of the stomach (P<0.05). There was strong EMMPRIN expression in all gastric carcinoma cell lines despite different levels of glycosylation. Extracellular MMP inducer expression was positively correlated with tumour size, depth of invasion, lymphatic invasion, expression of ki-67, MMP-2, MMP-9 and VEGF of tumours (P<0.05), but not with lymph node metastasis, UICC staging or differentiation (P>0.05). Interestingly, there was a significantly positive relationship between EMMPRIN expression and MVD in gastric carcinomas (P<0.05). Survival analysis indicated EMMPRIN expression to be negatively linked to favourable prognosis (P<0.05), but not be independent factor for prognosis (P>0.05). Further analysis showed three independent prognostic factors, depth of invasion, lymphatic and venous invasion, to influence the relationship between EMMPRIN expression and prognosis. Upregulated expression of EMMPRIN possibly contributes to genesis, growth and local invasion of gastric carcinomas. Altered EMMPRIN expression might enhance growth, invasion and angiogenesis of gastric carcinoma via upregulating MMP expression of both stromal fibroblasts and gastric cancer cells and could be considered as an objective and effective marker to predict invasion and prognosis

Incidental detection of an occult oral malignancy with autofluorescence imaging: a case report

BACKGROUND: Autofluorescence imaging is used widely for diagnostic evaluation of various epithelial malignancies. Cancerous lesions display loss of autofluorescence due to malignant changes in epithelium and subepithelial stroma. Carcinoma of unknown primary site presents with lymph node or distant metastasis, for which the site of primary tumour is not detectable. We describe here the use of autofluorescence imaging for detecting a clinically innocuous appearing occult malignancy of the palate which upon pathological examination was consistent with a metastatic squamous cell carcinoma. CASE DESCRIPTION: A submucosal nodule was noted on the right posterior hard palate of a 59-year-old white female during clinical examination. Examination of this lesion using a multispectral oral cancer screening device revealed loss of autofluorescence at 405 nm illumination. An excisional biopsy of this nodule, confirmed the presence of a metastatic squamous cell carcinoma. Four years ago, this patient was diagnosed with metastatic squamous cell carcinoma of the right mid-jugular lymph node of unknown primary. She was treated with external beam irradiation and remained disease free until current presentation. CONCLUSION: This case illustrates the important role played by autofluorescence tissue imaging in diagnosing a metastatic palatal tumour that appeared clinically innocuous and otherwise would not have been biopsied

HALT (Hernia Active Living Trial): protocol for a feasibility study of a randomised controlled trial of a physical activity intervention to improve quality of life in people with bowel stoma with a bulge/parastomal hernia

Background Parastomal hernia (PSH) can be repaired surgically, but results to date have been disappointing, with reported recurrence rates of 30 to 76%. Other types of intervention are therefore needed to improve the quality of life of people with PSH. One potential intervention is physical activity. We hypothesise that the intervention will increase core activation and control across the abdominal wall at a site of potential weakness and thus reduce the risk of PSH progression. Increases in physical activity will improve body image and quality of life (QoL). Methods Subjects and sample There were approximately 20 adults with a bowel stoma and PSH. People with previous PSH repair will be excluded as well as people who already do core training. Study design This is a feasibility study of a randomised controlled trial with 2 months follow-up, in 2 sites using mixed methods. Stage 1 involves intervention development and in stage 2, intervention and trial parameters will be assessed. Intervention A theoretically informed physical activity intervention was done, targeting people with PSH. Main outcome of feasibility study The main outcome is the decision by an independent Study Steering Committee whether to proceed to a full randomised controlled trial of the intervention. Other outcomes We will evaluate 4 intervention parameters—fidelity, adherence, acceptability and safety and 3 trial parameters (eligible patients’ consent rate, acceptability of study design and data availability rates for following endpoints): I. Diagnosis and classification of PSH II. Muscle activation III. Body composition (BMI, waist circumference) IV. Patient reported outcomes: QoL, body image and physical functioning V. Physical activity; VI. Psychological determinants of physical activity Other data Included are other data such as interviews with all participants about the intervention and trial procedures. Data analysis and statistical power As this is a feasibility study, the quantitative data will be analysed using descriptive statistics. Audio-recorded qualitative data from interviews will be transcribed verbatim and analysed thematically. Discussion The feasibility and acceptability of key intervention and trial parameters will be used to decide whether to proceed to a full trial of the intervention, which aims to improve body image, quality of life and PSH progression. Trial registration ISRCTN1520759

Aberrant expression of RAB1A in human tongue cancer

This study was designed to identify specific gene expression changes in tongue squamous cell carcinomas (TSCCs) compared with normal tissues using in-house cDNA microarray that comprised of 2304 full-length cDNAs from a cDNA library prepared from normal oral tissues, primary oral cancers, and oral cancer cell lines. The genes identified by our microarray system were further analysed at the mRNA or protein expression level in a series of clinical samples by real-time quantitative reverse transcriptase–polymerase chain reaction (qRT–PCR) analysis and imuunohositochemistry. The microarray analysis identified a total of 16 genes that were significantly upregulated in common among four TSCC specimens. Consistent with the results of the microarray, increased mRNA levels of selected genes with known molecular functions were found in the four TSCCs. Among genes identified, Rab1a, a member of the Ras oncogene family, was further analysed for its protein expression in 54 TSCCs and 13 premalignant lesions. We found a high prevalence of Rab1A-overexpression not only in TSCCs (98%) but also in premalignant lesions (93%). Thus, our results suggest that rapid characterisation of the target gene(s) for TSCCs can be accomplished using our in-house cDNA microarray analysis combined with the qRT–PCR and immunohistochemistry, and that the Rab1A is a potential biomarker of tongue carcinogenesis